Altered clock gene expression and vascular smooth muscle diurnal contractile variations in type 2 diabetic db/db mice

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 302, Issue 3, 2012, Pages

  Su, Wen ^a   Xie, Zhongwen ^a   Guo, Zhenheng ^a   Duncan, Marilyn J ^a   Lutshumba, Jenny ^a   Gong, Ming C ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Aorta; Blood pressure; Circadian rhythms; Thin filament binding proteins

Indexed keywords

ALPHA TROPOMYOSIN; ANGIOTENSIN II; BINDING PROTEIN; CALPONIN; CALPONIN 3; CRYPTOCHROME 1; CRYPTOCHROME 2; D SITE ALBUMIN PROMOTER BINDING PROTEIN; MESSENGER RNA; NUCLEAR RECEPTOR NR1D1; PER1 PROTEIN; PER2 PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHENYLEPHRINE; POTASSIUM ION; PROTEIN KINASE C; RHO KINASE; RHO KINASE 1; RHO KINASE 2; TRANSCRIPTION FACTOR CLOCK; TRANSGELIN; TROPOMYOSIN; TROPOMYOSIN 2; UNCLASSIFIED DRUG; VASOCONSTRICTOR AGENT;

ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; BLOOD PRESSURE MEASUREMENT; CIRCADIAN RHYTHM; CONTROLLED STUDY; ENCEPHALE ISOLE; GENE EXPRESSION; GENE REPRESSION; GENE TARGETING; HEART; HYPERTENSION; IN SITU HYBRIDIZATION; IN VIVO STUDY; INJECTION; ISOLATED HEART; ISOLATED KIDNEY; MALE; MESENTERIC ARTERY; MOUSE; MUSCLE ISOMETRIC CONTRACTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRESSOR RESPONSE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; TELEMETRY; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA; BLOOD PRESSURE; CIRCADIAN RHYTHM; CRYPTOCHROMES; DIABETES MELLITUS, TYPE 2; DNA-BINDING PROTEINS; GENE EXPRESSION; HEART; KIDNEY; MALE; MESENTERIC ARTERIES; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MUSCLE, SMOOTH, VASCULAR; PERIOD CIRCADIAN PROTEINS; PPAR GAMMA; SUPRACHIASMATIC NUCLEUS; TRANSCRIPTION FACTORS; VASOCONSTRICTION;

EID: 84856500834     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00825.2011     Document Type: Article

References (50)

1. Andreotti F, De Luca L, Renda G, Ferro A, Mongiardo R, Zecchi P, Maseri A. Circadianicity of hemostatic function and coronary vasomo-tion. Cardiologia 44, Suppl 1: 245-249, 1999.
2. Balsalobre A, Marcacci L, Schibler U. Multiple signaling pathways elicit circadian gene expression in cultured Rat-1 fibroblasts. CurrBiol 10: 1291-1294, 2000.
3. Bell RH Jr, Hye RJ. Animal models of diabetes mellitus: physiology and pathology. J Surg Res 35: 433-460, 1983.
4. Cardoso CR, Leite NC, Freitas L, Dias SB, Muxfeld ES, Salles GF. Pattern of 24-hour ambulatory blood pressure monitoring in type 2 diabetic patients with cardiovascular dysautonomy. Hypertens Res 31: 865-872, 2008.
5. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RE, Duyk GM, Tepper RI, Morgenstern JP. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84: 491-495, 1996.
6. Czupryniak L, Mlynarski W, Pawlowski M, Saryusz-Wolska M, Borkowska A, Klich I, Bodalski J, Loba J. Circadian blood pressure variation in normotensive type 2 diabetes patients and angiotensin converting enzyme polymorphism. Diabetes Res Clin Pract 80: 386-391, 2008.
7. Duncan MJ, Franklin KM, Davis VA, Grossman GH, Knoch ME, Glass JD. Short-term constant light potentiation of large-magnitude circadian phase shifts induced by 8-OH-DPAT: effects on serotonin receptors and gene expression in the hamster suprachiasmatic nucleus. Eur J Neurosci 22: 2306-2314, 2005.
8. Esser KA, Su W, Matveev S, Wong V, Zeng L, McCarthy JJ, Smart EJ, Guo Z, Gong MC. Voluntary wheel running ameliorates vascular smooth muscle hyper-contractility in type 2 diabetic db/db mice. Appl Physiol Nutr Metab 32: 711-720, 2007.
9. Fukuda M, Goto N, Kimura G. Hypothesis on renal mechanism of non-dipper pattern of circadian blood pressure rhythm. Med Hypotheses 67: 802-806, 2006.
10. Gohar M, Daleau P, Atkinson J, Gargouil YM. Ultradian variations in sensitivity of rat aorta rings to noradrenaline. Eur J Pharmacol 229: 69-73, 1992.
11. Goncalves AC, Tank J, Diedrich A, Hilzendeger A, Plehm R, Bader M, Luft FC, Jordan J, Gross V. Diabetic hypertensive leptin receptor-deficient db/db mice develop cardioregulatory autonomic dysfunction. Hypertension 53: 387-392, 2009.
12. Gong MC, Cohen P, Kitazawa T, Ikebe M, Masuo M, Somlyo AP, Somlyo AV. Myosin light chain phosphatase activities and the effects of phosphatase inhibitors in tonic and phasic smooth muscle. J Biol Chem 267: 14662-14668, 1992.
13. Gorgun CZ, Keskil ZA, Hodoglugil U, Ercan ZS, Abacioglu N, Zengil H. In vitro evidence of tissue susceptibility rhythms. I. Temporal variation in effect of potassium chloride and phenylephrine on rat aorta. Chronobiol Int 15: 39-48, 1998.
14. Guo Z, Su W, Allen S, Pang H, Daugherty A, Smart E, Gong MC. COX-2 up-regulation and vascular smooth muscle contractile hyperreactivity in spontaneous diabetic db/db mice. Cardiovasc Res 67: 723-735, 2005.
15. Halabi CM, Beyer AM, de Lange WJ, Keen HL, Baumbach GL, Faraci FM, Sigmund CD. Interference with PPAR-y function in smooth muscle causes vascular dysfunction and hypertension. Cell Metab 7: 215-226, 2008.
16. Hartshorne DJ. In: Physiology of the Gastrointestinal Tract, edited by Johnson LR. New York: Raven, 1987, p. 423-482.
17. Hirota T, Okano T, Kokame K, Shirotani-Ikejima H, Miyata T, Fukada Y. Glucose down-regulates Per1 and Per2 mRNA levels and induces circadian gene expression in cultured Rat-1 fibroblasts. J Biol Chem 277: 44244-44251, 2002.
18. Horiuti K. Mechanism of contracture on cooling of caffeine-treated frog skeletal muscle fibres. J Physiol 398: 131-148, 1988.
19. Hossmann V, Fitzgerald GA, Dollery CT. Circadian rhythm of barore-flex reactivity and adrenergic vascular response. Cardiovasc Res 14: 125-129, 1980.
20. Kamata K, Kojima S. Characteristics of contractile responses of aorta to norepinephrine in db/db mice. Res Commun Mol Pathol Pharmacol 96: 319-328, 1997.
21. Kanie N, Kamata K. Contractile responses in spontaneously diabetic mice. I. Involvement of superoxide anion in enhanced contractile response of aorta to norepinephrine in C57BL/KsJ(db/db) mice. Gen Pharmacol 35: 311-318, 2002.
22. Keskil Z, Gorgun CZ, Hodoglugil U, Zengil H. Twenty-four-hour variations in the sensitivity of rat aorta to vasoactive agents. Chronobiol Int 13: 465-475, 1996.
23. Kudo T, Akiyama M, Kuriyama K, Sudo M, Moriya T, Shibata S. Night-time restricted feeding normalises clock genes and Pai-1 gene expression in the db/db mouse liver. Diabetologia 47: 1425-1436, 2004.
24. Masuki S, Todo T, Nakano Y, Okamura H, Nose H. Reduced a-adre-noceptor responsiveness and enhanced baroreflex sensitivity in Cry-deficient mice lacking a biological clock. J Physiol 566: 213-224, 2005.
25. Nakano S, Uchida K, Kigoshi T, Azukizawa S, Iwasaki R, Kaneko M, Morimoto S. Circadian rhythm of blood pressure in normotensive NIDDM subjects. Its relationship to microvascular complications. Diabetes Care 14: 707-711, 1991.
26. Oishi K, Kasamatsu M, Ishida N. Gene- and tissue-specific alterations of circadian clock gene expression in streptozotocin-induced diabetic mice under restricted feeding. Biochem Biophys Res Commun 317: 330-334, 2004.
27. Oishi K, Ohkura N, Kasamatsu M, Fukushima N, Shirai H, Matsuda J, Horie S, Ishida N. Tissue-specific augmentation of circadian PAI-1 expression in mice with streptozotocin-induced diabetes. Thromb Res 114: 129-135, 2004.
28. Palmas W, Pickering T, Teresi J, Schwartz JE, Eguchi K, Field L, Weinstock RS, Shea S. Nocturnal blood pressure elevation predicts progression of albuminuria in elderly people with type 2 diabetes. J Clin Hypertens (Greenwich) 10: 12-20, 2008.
29. Pannirselvam M, Verma S, Anderson TJ, Triggle CR. Cellular basis of endothelial dysfunction in small mesenteric arteries from spontaneously diabetic (db/db-/-) mice: role of decreased tetrahydrobiopterin bioavailability. Br J Pharmacol 136: 255-263, 2002.
30. Park S, Bivona BJ, Feng Y, Lazartigues E, Harrison-Bernard LM. Intact renal afferent arteriolar autoregulatory responsiveness in db/db mice. Am J Physiol Renal Physiol 295: F1504-F1511, 2008.
31. Piercy V, Taylor SG. A comparison of spasmogenic and relaxant responses in aortae from C57/BL/KsJ diabetic mice with those from their non-diabetic litter mates. Pharmacology 56: 267-275, 1998.
32. Reppert SM, Weaver DR. Coordination of circadian timing in mammals. Nature 418: 935-941, 2002.
33. Rudic RD, Fulton DJ. Pressed for time: the circadian clock and hypertension. J Appl Physiol 107: 1328-1338, 2009.
34. Rudic RD, McNamara P, Reilly D, Grosser T, Curtis AM, Price TS, Panda S, Hogenesch JB, FitzGerald GA. Bioinformatic analysis of circadian gene oscillation in mouse aorta. Circulation 112: 2716-2724, 2005.
35. Sakamoto K, Nagase T, Fukui H, Horikawa K, Okada T, Tanaka H, Sato K, Miyake Y, Ohara O, Kako K, Ishida N. Multitissue circadian expression of rat period homolog (rPer2) mRNA is governed by the mammalian circadian clock, the suprachiasmatic nucleus in the brain. J Biol Chem 273: 27039-27042, 1998.
36. Senador D, Kanakamedala K, Irigoyen MC, Morris M, Elased KM. Cardiovascular and autonomic phenotype of db/db diabetic mice. Exp Physiol 94: 648-658, 2009.
37. 2+ sensitivity of smooth muscle and non-muscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83: 1325-1358, 2003.
38. Stephan FK, Davidson AJ. Glucose, but not fat, phase shifts the feeding-entrained circadian clock. Physiol Behav 65: 277-288, 1998.
39. Su W, Guo Z, Randall DC, Cassis L, Brown DR, Gong MC. Hypertension and disrupted blood pressure circadian rhythm in type 2 diabetic db/db mice. Am J Physiol Heart Circ Physiol 295: H1634-H1641, 2008.
40. Takahashi JS, Hong HK, Ko CH, McDearmon EL. The genetics of mammalian circadian order and disorder: implications for physiology and disease. Nat Rev Genet 9: 764-775, 2008.
41. Verdecchia P. Prognostic value of ambulatory blood pressure: current evidence and clinical implications. Hypertension 35: 844-851, 2000.
42. Wang N, Symons JD, Zhang H, Jia Z, Gonzalez FJ, Yang T. Distinct functions of vascular endothelial and smooth muscle PPAR-y in regulation of blood pressure and vascular tone. Toxicol Pathol 37: 21-27, 2009.
43. Wang N, Yang G, Jia Z, Zhang H, Aoyagi T, Soodvilai S, Symons JD, Schnermann JB, Gonzalez FJ, Litwin SE, Yang T. Vascular PPAR-y controls circadian variation in blood pressure and heart rate through Bmal1. Cell Metab 8: 482-491, 2008.
44. Welsh DK, Yoo SH, Liu AC, Takahashi JS, Kay SA. Bioluminescence imaging of individual fibroblasts reveals persistent, independently phased circadian rhythms of clock gene expression. Curr Biol 14: 2289-2295, 2004.
45. Witte K, Hasenberg T, Rueff T, Hauptfleisch S, Schilling L, Lemmer B. Day-night variation in the in vitro contractility of aorta and mesenteric and renal arteries in transgenic hypertensive rats. Chronobiol Int 18: 665-681, 2001.
46. Xie Z, Gong MC, Su W, Turk J, Guo Z. Group VIA phospholipase A2 (iPLA23) participates in angiotensin II-induced transcriptional up-regula-tion of regulator of G-protein signaling-2 in vascular smooth muscle cells. J Biol Chem 282: 25278-25289, 2007.
47. Xie Z, Su W, Guo Z, Pang H, Post SR, Gong MC. Up-regulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells. Cardiovasc Res 69: 491-501, 2006.
48. Yamamoto T, Nakahata Y, Soma H, Akashi M, Mamine T, Takumi T. Transcriptional oscillation of canonical clock genes in mouse peripheral tissues. BMC Mol Biol 5: 18, 2004.
49. Young ME, Razeghi P, Taegtmeyer H. Clock genes in the heart: characterization and attenuation with hypertrophy. Circ Res 88: 1142-1150, 2001.
50. Young ME, Wilson CR, Razeghi P, Guthrie PH, Taegtmeyer H. Alterations of the circadian clock in the heart by streptozotocin-induced diabetes. J Mol Cell Cardiol 34: 223-231, 2002.